Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spearmint extract + alpha-glyceryl phosphoryl choline + phosphatidylserine + pyrroloquinoline quinone is a multi-ingredient nootropic combination designed to support cognitive function, memory, and neuroprotection. This specific stack leverages the synergistic effects of four distinct compounds: **spearmint extract** (often standardized to rosmarinic acid, such as Neumentix), which provides antioxidant support and inhibits acetylcholinesterase; **alpha-glyceryl phosphoryl choline (Alpha-GPC)**, a highly bioavailable choline donor that increases brain acetylcholine levels; **phosphatidylserine (PS)**, a critical phospholipid for maintaining neuronal membrane integrity and facilitating cell-to-cell communication; and **pyrroloquinoline quinone (PQQ)**, a redox cofactor that stimulates mitochondrial biogenesis via the PGC-1alpha pathway. The combination is primarily marketed as a dietary supplement to address age-related cognitive decline, enhance focus, and support long-term brain health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on spearmint extract + alpha-glyceryl phosphoryl choline + phosphatidylserine + pyrroloquinoline quinone.